CastleKnight Management LP increased its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 6.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 389,433 shares of the company's stock after buying an additional 22,796 shares during the quarter. CastleKnight Management LP owned 0.96% of Phibro Animal Health worth $8,178,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of the stock. Sterling Capital Management LLC lifted its holdings in shares of Phibro Animal Health by 2.4% during the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company's stock worth $394,000 after buying an additional 448 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of Phibro Animal Health by 0.6% in the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock worth $1,608,000 after acquiring an additional 484 shares during the last quarter. Los Angeles Capital Management LLC boosted its holdings in shares of Phibro Animal Health by 2.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company's stock valued at $505,000 after buying an additional 503 shares in the last quarter. New York State Teachers Retirement System boosted its holdings in Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock worth $114,000 after purchasing an additional 775 shares during the last quarter. Finally, SG Americas Securities LLC lifted its position in shares of Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock valued at $276,000 after acquiring an additional 906 shares in the last quarter. 99.34% of the stock is owned by institutional investors.
Phibro Animal Health Trading Up 0.3 %
PAHC stock opened at $19.53 on Tuesday. The firm has a fifty day moving average price of $20.20 and a 200 day moving average price of $21.92. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The firm has a market cap of $791.02 million, a PE ratio of 40.69, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. Phibro Animal Health Co. has a fifty-two week low of $16.06 and a fifty-two week high of $26.55.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Sell-side analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on PAHC shares. Morgan Stanley set a $20.00 price target on shares of Phibro Animal Health in a report on Tuesday, April 15th. Barclays raised their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. Finally, StockNews.com downgraded shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a research note on Tuesday, March 25th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $19.75.
Get Our Latest Report on PAHC
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Co. (NASDAQ:PAHC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
